CV Sciences, Inc. Quarterly Debt-to-equity in % from Q3 2013 to Q2 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: CV Sciences, Inc. quarterly Debt-to-equity history and growth rate from Q3 2013 to Q2 2024.
CV Sciences, Inc. Debt-to-equity for the quarter ending June 30, 2024 was 222 %, a 46.8% decline year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q2 2024	222	-195	-46.8%	Jun 30, 2024
Q1 2024	194	-438	-69.3%	Mar 31, 2024
Q4 2023	162	-692	-81%	Dec 31, 2023
Q3 2023	276	-247	-47.3%	Sep 30, 2023
Q2 2023	417	+149	+55.7%	Jun 30, 2023
Q1 2023	633	+427	+207%	Mar 31, 2023
Q4 2022	855	+681	+393%	Dec 31, 2022
Q3 2022	522	+368	+238%	Sep 30, 2022
Q2 2022	268	+125	+88%	Jun 30, 2022
Q1 2022	206	+81	+64.8%	Mar 31, 2022
Q4 2021	173	+65.6	+60.9%	Dec 31, 2021
Q3 2021	154	+62.5	+67.9%	Sep 30, 2021
Q2 2021	142	+58	+68.8%	Jun 30, 2021
Q1 2021	125	+54	+76%	Mar 31, 2021
Q4 2020	108	+43.5	+67.5%	Dec 31, 2020
Q3 2020	92	+41.1	+80.9%	Sep 30, 2020
Q2 2020	84.4	+45.3	+116%	Jun 30, 2020
Q1 2020	71	+38.9	+121%	Mar 31, 2020
Q4 2019	64.4	+41	+175%	Dec 31, 2019
Q3 2019	50.9	+24.1	+90.2%	Sep 30, 2019
Q2 2019	39.1	+8.67	+28.5%	Jun 30, 2019
Q1 2019	32.1	-1.55	-4.6%	Mar 31, 2019
Q4 2018	23.4	-18.2	-43.8%	Dec 31, 2018
Q3 2018	26.7	-15.5	-36.7%	Sep 30, 2018
Q2 2018	30.5	-8.18	-21.2%	Jun 30, 2018
Q1 2018	33.7	-0.7	-2.04%	Mar 31, 2018
Q4 2017	41.6	+16.8	+68%	Dec 31, 2017
Q3 2017	42.3	+21.9	+107%	Sep 30, 2017
Q2 2017	38.6			Jun 30, 2017
Q1 2017	34.4			Mar 31, 2017
Q4 2016	24.7			Dec 31, 2016
Q3 2016	20.4			Sep 30, 2016
Q4 2014	2.68	-149	-98.2%	Dec 31, 2014
Q3 2014	10.3	-206	-95.3%	Sep 30, 2014
Q2 2014	22.3			Jun 30, 2014
Q1 2014	52.9			Mar 31, 2014
Q4 2013	152			Dec 31, 2013
Q3 2013	216			Sep 30, 2013

* An asterisk sign (*) next to the value indicates that the value is likely invalid.